I can see this long haulers trial getting confusing and leading to many other trials.

In long haulers what are we treating? Are we treating the virus? Nope. Are we treating the cytokine storm? I don't think so. Are we treating scores of other issues arising from some form of inflammation? Probably?

I can see leronlimab working. But then people still having 2 of their previous 20 problems, and then somehow we are not statistically significant.